Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2026-09-17 16:34:28 ET · period of report 2026-09-16 · accession 0001931406-26-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-17 16:34 | 2026-09-16 | MYGN | Sikri Vishal | EVP, Commercial | A - Grant | $0.00 | +257.7K | 351.2K | +276% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-16 | A | A | 257,731 | $0.00 | 351,224 | D | — | — | (F1) Consists of time-based restricted stock units granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date. |